Vertex Pharmaceuticals
VRTX
#177
Rank
โ‚ฌ100.12 B
Marketcap
394,15ย โ‚ฌ
Share price
-2.36%
Change (1 day)
-15.82%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): โ‚ฌ3.97 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ11.72 Billion. In 2024 the company made an earning of โ‚ฌ0.24 Billion a decrease over its 2023 earnings that were of โ‚ฌ3.86 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ3.97 B1531.31%
2024 โ‚ฌ0.24 B-93.69%
2023 โ‚ฌ3.86 B3.19%
2022 โ‚ฌ3.74 B53.56%
2021 โ‚ฌ2.43 B-12.06%
2020 โ‚ฌ2.77 B118.45%
2019 โ‚ฌ1.26 B120.64%
2018 โ‚ฌ0.57 B1473.64%
2017 โ‚ฌ36.53 M197.6%
2016 โ‚ฌ12.27 M-102.97%
2015 -โ‚ฌ0.42 Billion-28.46%
2014 -โ‚ฌ0.58 Billion-51.5%
2013 -โ‚ฌ1.2 Billion-30584.68%
2012 โ‚ฌ3.9 M-95.47%
2011 โ‚ฌ86.31 M
2009 -โ‚ฌ0.52 Billion
2007 -โ‚ฌ0.37 Billion83.1%
2006 -โ‚ฌ0.2 Billion59.02%
2005 -โ‚ฌ0.13 Billion3.28%
2004 -โ‚ฌ0.12 Billion-38.16%
2003 -โ‚ฌ0.2 Billion
2000 -โ‚ฌ33.21 Million-20.38%
1999 -โ‚ฌ41.71 Million31.62%
1998 -โ‚ฌ31.69 Million91.05%
1997 -โ‚ฌ16.59 Million-36.24%
1996 -โ‚ฌ26.01 Million12.45%
1995 -โ‚ฌ23.13 Million27.4%
1994 -โ‚ฌ18.16 Million-1833.33%
1993 โ‚ฌ1.04 M-112.12%
1992 -โ‚ฌ8.65 Million175%
1991 -โ‚ฌ3.15 Million-12.2%
1990 -โ‚ฌ3.58 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ28.27 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ1.44 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.62 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ20.15 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.01 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-โ‚ฌ66.22 Million-101.70%๐Ÿ‡บ๐Ÿ‡ธ USA